[1]
|
张婷, 李燕, 张莉, 孙瑾, 程向登. 早产儿追赶生长对体格、神经心理发育及代谢影响的研究进展[J]. 中国妇幼健康研究, 2020, 31(12): 1731-1734.
|
[2]
|
Chawanpaiboon, S., Vogel, J.P., Moller, A.B., Lumbiganon, P., Petzold, M., Hogan, D., Landoulsi, S., Jampathong, N., Kongwattanakul, K., Laopaiboon, M., Lewis, C., Rattanakanokchai, S., Teng, D.N., Thinkhamrop, J., Watananirun, K., Zhang, J., Zhou, W. and Gülmezoglu, A.M. (2019) Global, Regional, and Na-tional Estimates of Levels of Preterm Birth in 2014: A Systematic Review and Modelling Analysis. The Lancet Global Health, 7, e37-e46.
https://doi.org/10.1016/S2214-109X(18)30451-0
|
[3]
|
Ramenghi, L.A. (2015) Late Preterm Babies and the Risk of Neurological Damage. Acta Bio-Medica: Atenei Parmensis, 86, 36-40.
|
[4]
|
Zhu, Z., Yuan, L., Wang, J., Li, Q., Yang, C., Gao, X., Chen, S., Han, S., Liu, J., Wu, H., Yue, S., Shi, J., Cheng, R., Cheng, X., Han, T., Jiang, H., Bao, L. and Chen, C. (2021) Mortality and Morbidity of Infants Born Extremely Preterm at Tertiary Medical Centers in China from 2010 to 2019. JAMA Network Open, 4, e219382.
https://doi.org/10.1001/jamanetworkopen.2021.9382
|
[5]
|
Ren, Q., Zhang, X.F. and Yang, J.Y. (2016) Erythropoi-etin Reduces White Matter Damage in Two-Day-Old Rats Exposed to Hypoxic/Ischemia Injury. Neurological Research, 38, 1020-1026.
https://doi.org/10.1080/01616412.2016.1242451
|
[6]
|
Liu, W., Shen, Y., Plane, J.M., Pleasure, D.E. and Deng, W. (2011) Neuroprotective Potential of Erythropoietin and Its Derivative Carbamylated Erythropoietin in Periventricular Leukomalacia. Experimental Neurology, 230, 227-239.
https://doi.org/10.1016/j.expneurol.2011.04.021
|
[7]
|
Juul, S.E., Comstock, B.A., Wadhawan, R., Mayock, D.E., Courtney, S.E., Robinson, T., Ahmad, K.A., Bendel-Stenzel, E., Baserga, M., LaGamma, E.F., Downey, L.C., Rao, R., Fahim, N., Lampland, A., Frantz Iii, I.D., Khan, J.Y., Weiss, M., Gilmore, M.M., Ohls, R.K., Srinivasan, N., Perez, J.E., McKay, V., Vu, P.T., Lowe, J., Kuban, K., O’Shea, T.M., Hartman, A.L. and Heagerty, P.J. (2020) A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants. The New England Journal of Medicine, 382, 233-243. https://doi.org/10.1056/NEJMoa1907423
|
[8]
|
Malla, R.R., Asimi, R., Teli, M.A., Shaheen, F. and Bhat, M.A. (2017) Erythropoietin Monotherapy in Perinatal Asphyxia with Moderate to Severe Encephalopathy: A Randomized Pla-cebo-Controlled Trial. Journal of Perinatology: Official Journal of the California Perinatal Association, 37, 596-601. https://doi.org/10.1038/jp.2017.17
|
[9]
|
Xu, Y., Huang, L., Han, J. and Zhou, Y. (2022) Effects of EPO Combined with Mild Hypothermia on Oxidative Stress and Neuroprotection in Neonates with Hypoxic-Ischemic Encephalopathy. Cellular and Molecular Biology (Noisy-le-Grand, France), 68, 36-45. https://doi.org/10.14715/cmb/2022.68.4.5
|
[10]
|
荆春平, 朱丽华. 促红细胞生成素干预早产儿脑损伤机制的研究进展[J]. 临床与病理杂志, 2017, 37(7): 1500-1506.
|
[11]
|
Jantzie, L.L., Miller, R.H. and Robinson, S. (2013) Eryth-ropoietin Signaling Promotes Oligodendrocyte Development Following Prenatal Systemic Hypoxic-Ischemic Brain Inju-ry. Pediatric Research, 74, 658-667.
https://doi.org/10.1038/pr.2013.155
|
[12]
|
Vittori, D.C., Chamorro, M.E., Hernández, Y.V., Maltaneri, R.E. and Nesse, A.B. (2021) Erythropoietin and Derivatives: Potential Beneficial Effects on the Brain. Journal of Neurochemistry, 158, 1032-1057.
https://doi.org/10.1111/jnc.15475
|
[13]
|
Larpthaveesarp, A., Georgevits, M., Ferriero, D.M. and Gonzalez, F.F. (2016) Delayed Erythropoietin Therapy Improves Histological and Behavioral Outcomes after Transient Neonatal Stroke. Neurobiology of Disease, 93, 57-63.
https://doi.org/10.1016/j.nbd.2016.04.006
|
[14]
|
Strowitzki, M.J., Cummins, E.P. and Taylor, C.T. (2019) Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous? Cells, 8, Article No. 384. https://doi.org/10.3390/cells8050384
|
[15]
|
Niemann, T., Greiner, J.F.W., Kaltschmidt, C. and Kaltschmidt, B. (2023) EPO Regulates Neuronal Differentiation of Adult Human Neural-Crest Derived Stem Cells in a Sex-Specific Manner. BMC Neuroscience, 24, Article No. 19.
https://doi.org/10.1186/s12868-023-00789-1
|
[16]
|
Hemani, S., Lane, O., Agarwal, S., Yu, S.P. and Woodbury, A. (2021) Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies. Neurochemical Research, 46, 732-739.
https://doi.org/10.1007/s11064-021-03242-z
|
[17]
|
Wakhloo, D., Scharkowski, F., Curto, Y., Javed Butt, U., Bansal, V., Steixner-Kumar, A.A., Wüstefeld, L., Rajput, A., Arinrad, S., Zillmann, M.R., Seelbach, A., Hassouna, I., Schneider, K., Qadir Ibrahim, A., Werner, H.B., Martens, H., Miskowiak, K., Wojcik, S.M., Bonn, S., Nacher, J., Nave, K.A. and Ehrenreich, H. (2020) Functional Hypoxia Drives Neuroplasticity and Neurogenesis via Brain Erythropoietin. Nature Communications, 11, Article No. 1313.
https://doi.org/10.1038/s41467-020-15041-1
|
[18]
|
王建民, 薛梅, 杨青. 人重组促红细胞生成素在早产鼠脑室周围白质损伤模型鼠脑白质中的促血管新生作用及机制[J]. 临床和实验医学杂志, 2019, 18(16): 1710-1713.
|
[19]
|
Klepper, S., Jung, S., Dittmann, L., Geppert, C.I., Hartmann, A., Beier, N. and Trollmann, R. (2022) Further Evidence of Neuroprotective Effects of Recombinant Human Erythropoietin and Growth Hormone in Hypoxic Brain Injury in Neonatal Mice. International Journal of Molecular Sciences, 23, Article No. 8693.
https://doi.org/10.3390/ijms23158693
|
[20]
|
Lugano, R., Ramachandran, M. and Dimberg, A. (2020) Tumor Angi-ogenesis: Causes, Consequences, Challenges and Opportunities. Cellular and Molecular Life Sciences: CMLS, 77, 1745-1770.
https://doi.org/10.1007/s00018-019-03351-7
|
[21]
|
Si, W., Wang, J., Li, M., Qu, H., Gu, R., Liu, R., Wang, L., Li, S. and Hu, X. (2019) Erythropoietin Protects Neurons from Apoptosis via Activating PI3K/AKT and Inhibiting Erk1/2 Signaling Pathway. 3 Biotech, 9, Article No. 131.
https://doi.org/10.1007/s13205-019-1667-y
|
[22]
|
Zhang, W., Wu, Y., Chen, H., Yu, D., Zhao, J. and Chen, J. (2021) Neuroprotective Effects of SOX5 against Ischemic Stroke by Regulating VEGF/PI3K/AKT Pathway. Gene, 767, Article ID: 145148.
https://doi.org/10.1016/j.gene.2020.145148
|
[23]
|
刘盼月, 段淑荣, 曹国娟, 陈明. 脑梗死后HIF-1α及下游因子VEGF、SDF-1对神经干细胞作用的研究进展[J]. 脑与神经疾病杂志, 2018, 26(6): 393-396.
|
[24]
|
沈印, 葛剑, 李喆, 姚乐. 人重组促红细胞生成素对大鼠创伤性颅脑损伤后神经细胞凋亡的影响及机制研究[J]. 创伤外科杂志, 2020, 22(8): 592-595.
|
[25]
|
Wen, T.C., Sadamoto, Y., Tanaka, J., Zhu, P.X., Nakata, K., Ma, Y.J., Hata, R. and Sa-kanaka, M. (2002) Erythropoietin Protects Neurons against Chemical Hypoxia and Cerebral Ischemic Injury by Up-Regulating Bcl-xL Expression. Journal of Neuroscience Research, 67, 795-803. https://doi.org/10.1002/jnr.10166
|
[26]
|
Razak, A. and Hussain, A. (2019) Erythropoietin in Perinatal Hypox-ic-Ischemic Encephalopathy: A Systematic Review and Meta-Analysis. Journal of Perinatal Medicine, 47, 478-489. https://doi.org/10.1515/jpm-2018-0360
|
[27]
|
平莉莉, 张淑彦, 翟淑芬. 宫内感染早产儿脑损伤与血清炎症因子水平的相关性[J]. 儿科药学杂志, 2019, 25(8): 4-6.
|
[28]
|
兰海涛, 张庆俊. 重组人促红细胞生成素对大鼠局灶性脑缺血再灌注炎症损伤的保护作用[J]. 中华神经外科杂志, 2006, 22(1): 51-54.
|
[29]
|
Genc, K., Genc, S., Baskin, H. and Semin, I. (2006) Erythropoietin Decreases Cytotoxicity and Nitric Oxide Formation Induced by Inflammatory Stimuli in Rat Oligodendrocytes. Physiological Research, 55, 33-38.
https://doi.org/10.33549/physiolres.930749
|
[30]
|
钟欣, 栾佐, 臧静, 管倩, 杨印祥, 王倩, 史源. 人少突胶质前体细胞移植对脑白质损伤大鼠的保护作用[J]. 中国当代儿科杂志, 2021, 23(4): 410-415.
|
[31]
|
Boulanger, J.J. and Messier, C. (2014) From Precursors to Myelinating Oligodendrocytes: Contribution of Intrinsic and Extrinsic Factors to White Matter Plasticity in the Adult Brain. Neuroscience, 269, 343-366.
https://doi.org/10.1016/j.neuroscience.2014.03.063
|
[32]
|
许恒正, 吴志猛, 程孝中. 促红细胞生成素对神经退行性疾病的作用[J]. 生物学杂志, 2020, 37(5): 94-98.
|
[33]
|
朱萍, 李德亮, 张伟业. 重组人促红细胞生成素治疗新生儿缺氧缺血性脑病的效果分析[J]. 中国实用神经疾病杂志, 2020, 23(24): 2176-2180.
|
[34]
|
Bond, W.S. and Rex, T.S. (2014) Evidence That Erythropoietin Modulates Neuroinflammation through Differential Action on Neurons, As-trocytes, and Microglia. Frontiers in Immunology, 5, Article No. 523.
https://doi.org/10.3389/fimmu.2014.00523
|
[35]
|
Iughetti, L., Lucaccioni, L., Fugetto, F., Predieri, B., Berardi, A. and Ferrari, F. (2018) Brain-Derived Neurotrophic Factor and Epilepsy: A Systematic Review. Neuropeptides, 72, 23-29. https://doi.org/10.1016/j.npep.2018.09.005
|
[36]
|
Jin, T., Zhang, Y., Botchway, B.O.A., Zhang, J., Fan, R., Zhang, Y. and Liu, X. (2022) Curcumin Can Improve Parkinson’s Disease via Activating BDNF/PI3k/Akt Signaling Pathways. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Asso-ciation, 164, Article ID: 113091.
https://doi.org/10.1016/j.fct.2022.113091
|
[37]
|
金宝, 张育才, 崔云. 促红细胞生成素对发育期小鼠脑损伤后脑源性神经营养因子和酪氨酸受体激酶B表达的影响[J]. 上海交通大学学报(医学版), 2012, 32(1): 14-20.
|
[38]
|
Alexander, M.L., Hill, C.A., Rosenkrantz, T.S. and Fitch, R.H. (2012) Evaluation of the Therapeutic Benefit of Delayed Administration of Erythropoietin Following Early Hypoxic-Ischemic Injury in Rodents. Developmental Neu-roscience, 34, 515-524. https://doi.org/10.1159/000345645
|
[39]
|
McPherson, R.J. and Juul, S.E. (2010) Erythro-poietin for Infants with Hypoxic-Ischemic Encephalopathy. Current Opinion in Pediatrics, 22, 139-145. https://doi.org/10.1097/MOP.0b013e328336eb57
|
[40]
|
陈清, 钱霜霜, 周丽, 娄冉. 出生后早期大剂量促红细胞生成素对早产儿脑发育的保护作用[J]. 中华全科医学, 2020, 18(1): 74-77.
|
[41]
|
周匡果, 周向阳, 常立文. 重组人类促红细胞生成素治疗新生儿缺血缺氧性脑病疗效及安全性Meta分析[J]. 中国实用儿科杂志, 2011, 26(10): 770-776.
|
[42]
|
Huang, C.T., Chen, S.H., Lin, S.C., Chen, W.T., Lue, J.H. and Tsai, Y.J. (2018) Erythropoietin Reduces Nerve Demyelination, Neuropathic Pain Behavior and Microglial MAPKs Activation through Erythropoietin Receptors on Schwann Cells in a Rat Model of Peripheral Neuropathy. Glia, 66, 2299-2315. https://doi.org/10.1002/glia.23461
|
[43]
|
Ma, Y., Zhou, Z., Yang, G.Y., Ding, J. and Wang, X. (2022) The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review. Frontiers in Pharmacology, 13, Article ID: 743926.
https://doi.org/10.3389/fphar.2022.743926
|
[44]
|
Macias-Velez, R.J., Fukushima-Díaz de León, L., Beas-Zárate, C. and Rivera-Cervantes, M.C. (2019) Intranasal Erythropoietin Protects CA1 Hippocampal Cells, Modulated by Specific Time Pattern Molecular Changes after Ischemic Damage in Rats. Journal of Molecular Neuroscience: MN, 68, 590-602. https://doi.org/10.1007/s12031-019-01308-w
|
[45]
|
Chiu, P.C., Liou, H.C., Ling, T.Y. and Shen, L.J. (2020) De-velopment of a Neuroprotective Erythropoietin Modified with a Novel Carrier for the Blood-Brain Barrier. Neurothera-peutics: The Journal of the American Society for Experimental NeuroTherapeutics, 17, 1184-1196. https://doi.org/10.1007/s13311-020-00845-2
|
[46]
|
Juul, S.E., McPherson, R.J., Bauer, L.A., Ledbetter, K.J., Gleason, C.A. and Mayock, D.E. (2008) A Phase I/II Trial of High-Dose Erythropoietin in Extremely Low Birth Weight Infants: Pharmacokinetics and Safety. Pediatrics, 122, 383-391. https://doi.org/10.1542/peds.2007-2711
|
[47]
|
Neubauer, A.P., Voss, W., Wachtendorf, M. and Jungmann, T. (2010) Erythropoietin Improves Neurodevelopmental Outcome of Extremely Preterm Infants. Annals of Neurology, 67, 657-666. https://doi.org/10.1002/ana.21977
|
[48]
|
Andropoulos, D.B., Brady, K., Easley, R.B., Dickerson, H.A., Voigt, R.G., Shekerdemian, L.S., Meador, M.R., Eisenman, C.A., Hunter, J.V., Turcich, M., Rivera, C., McKenzie, E.D., Heinle, J.S. and Fraser, C.D. (2013) Erythropoietin Neuroprotection in Neonatal Cardiac Surgery: A Phase I/II Safety and Efficacy Trial. The Journal of Thoracic and Cardiovascular Surgery, 146, 124-131. https://doi.org/10.1016/j.jtcvs.2012.09.046
|
[49]
|
Juul, S.E. and Pet, G.C. (2015) Erythropoietin and Neonatal Neu-roprotection. Clinics in Perinatology, 42, 469-481.
https://doi.org/10.1016/j.clp.2015.04.004
|
[50]
|
Perrone, S., Lembo, C., Gironi, F., Petrolini, C., Catalucci, T., Corbo, G., Buonocore, G., Gitto, E. and Esposito, S.M.R. (2022) Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use. Antioxidants (Basel, Switzerland), 11, Article No. 652. https://doi.org/10.3390/antiox11040652
|
[51]
|
Brown, M.S., Eichorst, D., Lala-Black, B. and Gonzalez, R. (2009) Higher Cumulative Doses of Erythropoietin and Developmental Outcomes in Preterm Infants. Pediatrics, 124, e681-e687. https://doi.org/10.1542/peds.2008-2701
|
[52]
|
陈颖, 吴多江, 杨亦彬, 柯贵宝, 张富祥, 容松. 促红细胞生成素干预肾缺血再灌注损伤后肾小管间质的纤维化[J]. 中国组织工程研究, 2012, 16(40): 7514-7519.
|